Immuno-NeuroPsychiatry on the Path to Clinical Application
Livia De Picker,Dominique Endres,Michael E. Benros,Marion Leboyer
DOI: https://doi.org/10.1016/j.psyneuen.2023.106774
IF: 4.693
2024-02-01
Psychoneuroendocrinology
Abstract:This symposium, organized by the ECNP Network for Immuno-NeuroPsychiatry, aims to show where immunoneuropsychiatry stands on the road to clinical application and to identify remaining obstacles. Immune processes contribute to the functioning of the central nervous system, but the risk of developing mental illness is greater in patients with dysfunctions of the immune mechanisms. Some brain diseases, such as autoimmune encephalitis, may even be causally induced by immune dysfunction, for example, when autoantibodies bind to brain receptors and disturb their function. The detection of such processes in psychiatry is highly significant for clinicians, as patients with autoimmune-mediated diseases can potentially be treated by immunomodulatory drugs (Pollak et al., 2020, Lancet Psychiatry). Prof. Marion Leboyer will act as discussant to moderate and integrate the three presentations: In the first presentation, Livia de Picker (from Duffel/Belgium) provides insights into the patterns of microglial activation across different brain disorders. In particular, she presents the results from a transdiagnostic meta- analysis of 156 human CNS TSPO PET case-control studies (De Picker et al., 2023, in review) and the findings from a human TSPO PET study and post-mortem study of patients with psychosis (De Picker et al., 2019 and 2021, Brain, Behavior, and Immunity). Next, Dominique Endres (from Freiburg/Germany) will present exemplary cases and the first case series and clinical experiences with immunotherapies from patients with suspected autoimmune encephalitis and isolated psychiatric manifestations (Endres et al., 2022, Molecular Psychiatry). He will also show that the spectrum of autoantibodies against brain structures may be broader in psychotic patients than initially believed (Endres et al., 2022, Biological Psychiatry). In the last presentation, Michael E. Benros (from Copenhagen, Denmark) will provide an overview of biomarkers for autoimmune psychiatric syndromes, with particular reference to recent results from cerebrospinal fluid (CSF) studies. His research group is currently conducting the largest controlled CSF studies in patients with psychosis and depression (e.g., Mousten…Benros, 2022, JAMA Psychiatry; Sørensen…Benros, 2022, Biological Psychiatry; Jeppesen…Benros, 2022, Schizophrenia Bulletin). He will also present meta-analytical results of studies with anti-inflammatory drugs in patients with severe mental disorders (Jeppesen…Benros, 2020, Brain Behavior and Immunity; Kohler-Forsberg…Benros, 2019, Acta Psychiatr Scand).
neurosciences,endocrinology & metabolism,psychiatry